# Nanovision Technology (Beijing) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanovision-technology-beijing-co

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.nanovision.com.cn
- Total disclosed funding: $23M
- Latest round: Series C (Dec 3, 2025)
- Investors on record: 5

## About

Based in China and founded in 2014, Nanovision Technology (Beijing) Co., Ltd. is a high-tech enterprise specializing in high-speed, high-precision radiation imaging. The company has established subsidiaries in Chengdu and Shanghai and has obtained more than 100 intellectual property rights, including PCT, national patents, software copyrights, integrated circuit layout-design patents, and so on.

In December 2025, Nanovision Technology (Beijing) Co., Ltd. closed series C+ funding from new investor Zijin Venture Capital.

Nanovision Technology (Beijing) Co., Ltd. provides static CT system and solutions applied for medical industry and security check. The company also offers medical radiography software such as nvDR software and nvDRF dynamic software. The company generates revenue from providing static CT system and solutions and medical radiography software.

The series C+ financing will be mainly used to advance the commercialization of static CT products and the iteration of core technologies.

## Funding rounds

- Series C, Dec 3, 2025 — Zijin Venture Capital
- Series B, Dec 31, 2019, $23M — Sherpa Healthcare Partners
- Series A, Sep 26, 2018 — Sherpa Healthcare Partners
- Series A, Mar 22, 2018 — Hillhouse Investment, Anchao Capital
- Angel, Sep 28, 2017 — Legend Capital

## Investors

- Legend Capital — Angel
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series A
- Anchao Capital (https://capitalatlas.ai/funds/anchao-capital) — Series A
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series A, Series B
- Zijin Venture Capital (https://capitalatlas.ai/funds/zijin-venture-capital) — Series C